Clinical Trials
3 trialsNCT06102824 2024-11-25
ORIENTA
Guangdong Provincial People's Hospital
Phase 2 Recruiting
NCT05263882 2022-03-03
Gemcitabine Combined With Eribulin Regimen in the Treatment of Second-line Above Recurrent HER2-negative Breast Cancer
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 2 Unknown
NCT04624711 2021-05-21
Eribulin Combined With Anlotinib in Metastatic HER2 Negative Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown